Evidence map›Paper›PMID 30915068›Full record

ArticleFrontiers in immunology2019

Super-Low Dose Lipopolysaccharide Dysregulates Neutrophil Migratory Decision-Making.

Brittany P Boribong, Mark J Lenzi, Liwu Li, Caroline N Jones

Abstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Leveraging Microphysiological Systems to Facilitate Neutrophil-Based Cancer Immunotherapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in immunology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Neutrophil dysfunction in cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Brittany P BoribongGenetics, Bioinformatics, and Computational Biology, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.
Mark J LenziDepartment of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.
Liwu LiDepartment of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.
Caroline N JonesDepartment of Biological Sciences, Virginia Polytechnic Institute and State University, Blacksburg, VA, United States.

Funding

VT Initiative for Maximizing Student DiversityR25GM072767 · NIGMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI SMITH, EDWARD J · 2007 to 2021
$6.9M
Altered innate leukocyte programming dynamics in sepsisR01AI136386 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI LI, LIWU · 2018 to 2022
$2.0M
NIAID NIH HHS R01 AI136386NIGMS NIH HHS R25 GM072767
6 · The paper itself

Abstract

Neutrophils are the first responders to infection and play a pivotal role in many inflammatory diseases, including sepsis. Recent studies have shown that lipopolysaccharide (LPS), a classical pattern recognition molecule, dynamically programs innate immune responses. In this study, we show that pre-treatment with super-low levels of LPS [1 ng/mL] significantly dysregulate neutrophil migratory phenotypes, including spontaneous migration and altering neutrophil decision-making. To quantify neutrophil migratory decision-making with single-cell resolution, we developed a novel microfluidic competitive chemotaxis-chip (μC

Indexed as

Cell SurvivalChemotactic FactorsChemotaxis, LeukocyteHL-60 CellsHumansImmunity, InnateInflammationLab-On-A-Chip DevicesLeukotriene B4LipopolysaccharidesNeutrophilsN-Formylmethionine Leucyl-PhenylalanineChemotactic FactorsLeukotriene B4LipopolysaccharidesN-Formylmethionine Leucyl-Phenylalaninechemotaxisgradientslipopolysaccharidemicrofluidicsneutrophil memoryneutrophilssepsis

Identifiers

PMID30915068
PMCPMC6422936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.